Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-16 Purchase |
2025-04-18 3:17 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
128,713 | $11.32 | $1,456,408 | 17,828,487 (Indirect) |
View |
| 2025-04-03 Purchase |
2025-04-07 6:34 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
317,208 | $11.42 | $3,623,970 | 17,699,774 (Indirect) |
View |
| 2025-03-31 Purchase |
2025-04-02 7:02 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
127,415 | $11.75 | $1,497,322 | 17,382,566 (Indirect) |
View |
| 2025-03-25 Purchase |
2025-03-27 6:53 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
97,349 | $12.61 | $1,227,309 | 17,255,151 (Indirect) |
View |
| 2025-03-20 Purchase |
2025-03-24 5:45 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
127,198 | $12.92 | $1,643,248 | 17,157,802 (Indirect) |
View |
| 2025-03-17 Purchase |
2025-03-19 6:32 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
228,463 | $12.55 | $2,866,553 | 17,030,604 (Indirect) |
View |
| 2025-03-11 Purchase |
2025-03-13 7:35 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
1,081,980 | $12.13 | $13,120,914 | 16,802,141 (Indirect) |
View |
| 2025-01-16 Purchase |
2025-01-21 5:34 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
141,429 | $13.88 | $1,963,538 | 15,720,161 (Indirect) |
View |
| 2025-01-13 Purchase |
2025-01-15 6:12 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
167,654 | $13.59 | $2,278,811 | 15,578,732 (Indirect) |
View |
| 2025-01-08 Purchase |
2025-01-10 6:27 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
225,119 | $13.21 | $2,974,819 | 15,411,078 (Indirect) |
View |
| 2024-12-30 Purchase |
2025-01-02 6:17 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
85,098 | $12.92 | $1,099,642 | 7,880,094 (Indirect) |
View |
| 2024-12-30 Purchase |
2025-01-02 5:51 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
363,369 | $14.64 | $5,321,176 | 15,185,959 (Indirect) |
View |
| 2024-12-24 Purchase |
2024-12-27 6:41 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
130,309 | $14.44 | $1,882,115 | 14,822,590 (Indirect) |
View |
| 2024-12-19 Purchase(A) |
2024-12-26 12:46 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner |
1,254,808 | $13.98 | $17,544,284 | 14,692,281 (Indirect) |
View |
| 2024-11-06 Sale |
2024-11-08 7:24 pm |
Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner |
2,700,000 | $3.1243 | $8,435,743 | 10,630,736 (Indirect) |
View |
| 2024-08-14 Purchase |
2024-08-16 12:04 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner |
273,972 | $36.5 | $9,999,978 | 7,794,996 (Indirect) |
View |
| 2023-09-19 Purchase(A) |
2023-09-22 3:44 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
5,313,100 | $1.2596 | $6,692,265 | 12,674,775 (Indirect) |
View |
| 2023-02-19 Purchase |
2023-09-21 8:08 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
5,313,100 | $1.2596 | $6,692,265 | 19,209,643 (Indirect) |
View |
| 2023-06-16 Purchase |
2023-06-21 4:04 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
3,350,000 | $8.12 | $27,202,000 | 13,437,473 (Indirect) |
View |
| 2023-04-28 Sale |
2023-05-02 5:15 pm |
Panacea Acquisition Corp. II | PANA | EcoR1 Panacea Holdings II LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC NODELMAN OLEG Director 10% Owner |
545,000 | $0 | $0 | 0 (Direct) |
View |
| 2023-03-28 Purchase |
2023-03-30 5:47 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
200,000 | $8 | $1,600,000 | 10,087,473 (Indirect) |
View |
| 2023-01-19 Purchase |
2023-01-23 6:00 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
307,500 | $9.6999 | $2,982,733 | 9,887,473 (Indirect) |
View |
| 2023-01-13 Purchase |
2023-01-18 6:27 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
985,100 | $9.8442 | $9,697,527 | 9,579,973 (Indirect) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:47 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
1,026,300 | $7.6723 | $7,874,083 | 8,594,873 (Indirect) |
View |
| 2023-01-09 Sale |
2023-01-11 6:26 pm |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
902,400 | $7.9148 | $7,142,343 | 3,851,507 (Indirect) |
View |
| 2022-06-21 Purchase |
2022-06-23 5:21 pm |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
477,400 | $5.5761 | $2,662,047 | 4,753,907 (Indirect) |
View |
| 2022-05-05 Purchase |
2022-05-09 06:04 am |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner |
668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) |
View |
| 2022-05-05 Sale |
2022-05-09 06:04 am |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner |
668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) |
View |
| 2022-05-05 Purchase |
2022-05-09 06:01 am |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
1,062,736 | $29.02 | $30,840,599 | 11,584,280 (Indirect) |
View |
| 2022-05-05 Sale |
2022-05-09 06:01 am |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
1,062,736 | $29.02 | $30,840,599 | 11,584,280 (Indirect) |
View |
| 2022-01-12 Purchase |
2022-01-12 6:12 pm |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
300,000 | $37.5 | $11,250,300 | 11,584,280 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-19 Other |
2024-12-23 7:42 pm |
2024-12-20 N/A |
Mersana Therapeutics Inc. | MRSN | EcoR1 Capital LLC 10% Owner |
8,036,688 | $0 | 27,401,376 (Indirect) |
View |
Ownership |
2024-03-26 12:00 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | EcoR1 Capital LLC 10% Owner |
0 | $0 | 164,424,420 (Indirect) |
View |
Ownership |
2023-12-27 4:04 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | EcoR1 Capital LLC 10% Owner |
0 | $0 | 7,396,979 (Indirect) |
View |
Ownership |
2023-10-16 3:42 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner |
0 | $0 | 13,330,736 (Indirect) |
View |
Ownership |
2023-07-31 1:55 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | EcoR1 Capital LLC 10% Owner |
0 | $0 | 19,364,688 (Indirect) |
View |
Ownership |
2023-06-05 4:09 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,000,000 (Indirect) |
View |
Ownership |
2023-01-06 9:30 pm |
N/A N/A |
Graphite Bio Inc. | GRPH | EcoR1 Capital LLC 10% Owner |
0 | $0 | 8,538,446 (Indirect) |
View |
Ownership |
2022-11-01 3:23 pm |
N/A N/A |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
0 | $0 | 7,568,573 (Indirect) |
View |
Ownership |
2022-04-25 9:30 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
0 | $0 | 4,276,507 (Indirect) |
View |